**Background:** Honey is a complex natural food matrix containing over 300 chemical substances and is valued for its antimicrobial properties and traditional medicinal use. Contamination of honey by antibiotic residues, particularly sulfonamides (SAs) and tetracyclines (TCs), has been frequently reported due to their use in apiculture to treat bacterial infections such as American foulbrood. Chronic exposure to residual antibiotics can cause liver injury, allergic reactions, damage to bones and teeth, and contribute to antimicrobial resistance, which the WHO has classified as 'one of the greatest threats to public health.' No maximum residue limits (MRLs) for antibiotics in honey exist in Egypt, Libya, or Saudi Arabia, though Swiss authorities have set MRLs of 50 µg/kg for SAs and 20 µg/kg for TCs. This study aimed to introduce and validate multi-residue methods for determining SAs and TCs in honey, survey their occurrence across three Arabian countries, and assess potential health risks.
**Methods:** Eighty-four honey samples were collected: 33 from Egypt (7 regions), 33 from Libya (8 regions), and 18 from Saudi Arabia (6 regions). Samples were pure, unfiltered, and unprocessed. Six antibiotics were targeted: sulfamethazine (SMT), sulfamethoxazole (SMX), sulfadimethoxine (SDM), oxytetracycline (OTC), tetracycline (TC), and chlortetracycline (CTC). Two extraction methods were employed: (1) matrix solid-phase dispersion (MSPD) using diatomaceous earth for SAs, eluted with acetone and acetonitrile; (2) EDTA McIlvain's buffer (pH 4.5) with 10% TCA and SPE clean-up using Oasis HLB 200 mg cartridges for TCs. Analysis was performed using HPLC-DAD (Agilent 1100) and HPLC-MS/MS (Agilent 1260 with Thermo Finnigan LCQ Duo ion trap). Method validation assessed linearity, detection limits (DL), quantification limits (QL), accuracy, and precision. Risk assessment used estimated daily intake (EDI), source-related hazard quotient (HQ_S), source-related hazard index (HI_S), and adversity-specific hazard index (HI_A), with ADI values of 3 µg/kg bw/day for SAs and 5 µg/kg bw/day for TCs.
**Key Results:** HPLC-MS/MS showed markedly lower DLs (0.01–0.04 ng/g) compared to HPLC-DAD (2.5–21 ng/g). The MSPD method achieved high accuracy for SAs (83.07–86.93%) but low recovery for TCs (45.48–50.20%). The EDTA buffer method achieved high accuracy for TCs (86.90–91.19%) but low recovery for SAs (57.81–65.63%). RSD values for all methods were below 15%, meeting EU directive 2002/657/EC requirements. In Egypt, 57.6% of samples (19/33) were positive for antibiotics; SMT and SMX showed 100% incidence in positive samples, while SDM was not detected. The highest average concentrations were SMX in Giza (86.9 µg/kg) and TC in Dakahlia (131.75 µg/kg). In Libya, 75% of samples (18/24) were positive, with TCs dominating; 87.5% of positive samples exceeded Swiss MRLs. CTC showed the highest average concentration (157.32 µg/kg), followed by TC (137.21 µg/kg). In Saudi Arabia, 77.7% of samples (14/18) were positive; SAs were most abundant (78.5% of positive samples), with SMT averaging 8.54 µg/kg and SMX 5.40 µg/kg. TC was detected in Abha and Al Bahah at 76.53 and 124.09 µg/kg, respectively. All HQ_S values were markedly below 1, with the highest for CTC in Libya (0.166) and TC in Libya (0.145). HI_S values for SAs were highest in Libya (0.338), followed by Saudi Arabia (0.168) and Egypt (0.156). HI_A values for both antibiotic groups were within safe ranges.
**Clinical Implications:** The study demonstrates that validated HPLC-DAD and HPLC-MS/MS methods are suitable for routine monitoring of antibiotic residues in honey. While the risk assessment indicates no immediate health threat from honey consumption alone, the detection of concentrations exceeding Swiss MRLs—particularly in Libyan samples where 87.5% of positive samples exceeded limits—highlights the need for regulatory action. The authors note that chronic exposure to antibiotics, especially from samples with the highest detected concentrations (e.g., SMX at 275.08 µg/kg in Giza, CTC at 462.48 µg/kg in Khoms), could represent a potential public health risk. The findings support calls for international bodies such as the EU and US FDA to establish MRLs for antibiotics in honey and for improved control of antibiotic use in apiculture, including natural alternatives.